The Seed Investor
Early Stage Investing
Join our Newsletter  Hand-picked cannabis stocks, news & alerts straight to your inbox (100% FREE!)
  •  
  • Cannabis News
  • Marijuana Industry
  • Marijuana Investing
  • Psychedelics
  • Featured Companies
  • TSI Exclusive
  • About
    • Overview
    • Disclaimer
    • Advertise
    • Privacy Policy

Trending Now

  • MCUR’s $10 Million Financing Triples Cash Reserves, Powers Operations Strategies
  • Mind Cure Establishes Psychedelic Compound Research Program
  • Compass Pathways Files For NASDAQ Listing: Psychedelics Game-Changer
  • MindMed And Eleusis Lead The Way In Psychedelics Micro-Dosing Research
  • Why Psychedelics Micro-Dosing Applications Have The Inside Track On Commercialization
  • Cannabis Sales Soar 48% In 2019, 2020 Looking Even Stronger
Psychedelic Stocks
Exploring the companies and themes that make up this emerging and exciting new sector

Psychedelic Drugs And The Placebo Effect

2021-03-11 PSW Editor

Part of the benefit from psychedelic medicine may actually be a Placebo Effect. Find out why that is actually a GOOD thing.

Lifetime psychedelic use may reduce likelihood of hypertension

2021-03-11 Scott Buzby

Lifetime classic psychedelic use, particularly tryptamines, may be linked to lower odds for hypertension in the previous year, according to data published in Hypertension.

Psychedelics research: Scientists zero in on the ideal dose of LSD to use in psychiatric treatment

2021-03-10 Eric W. Dolan

New research published in Neuropsychopharmacology provides insight into the acute dose dependent effects of LSD.

COMPASS Pathways plc announces financial results and business highlights for fourth quarter and year-end 2020

2021-03-09 PSW Editor

Compass expecting to report data from its Phase IIb study by the end of 2021. Cash on hand decreases to $190.3 million, from $196.5 million the previous quarter.

Cybin Announces API Synthesis and Optimization of Multiple Tryptamine Derivatives and Nomination of Two Deuterated Candidates for Full IND Enabling Studies Based on Second Milestone Achievement Pursuant to the Adelia Acquisition

2021-03-09 PSW Editor

Adelia Therapeutics, a subsidiary of Cybin Corp., achieves API synthesis and optimization on trypatmine derivatives.

Red Light Holland's Psychedelic Virtual Reality Experience, Wisdom, Narrated by Global Comedy Superstar Russell Peters, Accepted to Steam, the Largest Digital Distribution Platform for PC Gaming

2021-03-09 PSW Editor

Red Light Holland gets its VR "experience" hosted on the largest PC gaming platform.

WATCH - Mydecine Co-Founder Damon Michaels: It’s Time To Make Alternative Medicine Traditional Medicine

2021-03-09 Amanda Siebert

Damon Michaels, chief operating officer of emerging biotech and life sciences company Mydecine sat down with The Dales Report last week to discuss the company’s latest activity.

New York Lawmaker Files Bill To Decriminalize Psilocybin Mushrooms

2021-03-09 Kyle Jaeger

A New York lawmaker is proposing to decriminalize psychedelic mushrooms in the state.

MindMed Announces C$19.5 Million Bought Deal Private Placement Offering

2021-03-08

MindMed raises CAD$19.5 million selling units at CAD$3.25.

Previous antidepressant use may blunt the effectiveness of MDMA-assisted psychotherapy for PTSD

2021-03-08 Eric W. Dolan

New research suggests that MDMA-assisted therapy for the treatment of posttraumatic stress disorder (PTSD) is less effective among those who have recently used selective serotonin reuptake inhibitors (SSRIs), a common psychiatric medication.

The Race to Patent Psychedelics Is Just Getting Started

2021-03-05 Shayla Love

The author and podcast host Tim Ferriss has done his share of heavy lifting when it comes to supporting and promoting research on psychedelic drugs.

Local Activists In Washington State Push For Psilocybin Decriminalization

2021-03-05 Kyle Jaeger

Voters in Spokane, Washington could make the city one of the latest to decriminalize psilocybin mushrooms under a proposed ordinance that was recently filed by local activists.

  • Previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • ...
  • 35
  • Next
Join our Newsletter
 Hand-picked cannabis stocks, news & alerts straight to your inbox (100% FREE!)

The Seed Investor Exclusive

MCUR’s $10 Million Financing Triples Cash Reserves, Powers Operations Strategies

MCUR’s $10 Million Financing Triples Cash Reserves, Powers Operations Strategies

2021-01-21
Mind Cure announces a CAD$10 million bought deal financing at a unit price of CAD$0.60. Proceeds will be directed toward product research development and related tech initiatives like its iSTRYM digital therapeutics platform.

Mind Cure Establishes Psychedelic Compound Research Program

Compass Pathways Files For NASDAQ Listing: Psychedelics Game-Changer

The Psychedelics Revolution: From ‘War on Drugs’ To Funding Psychedelic Drug Research

Eleusis Looks For Alzheimer’s Breakthrough With Micro-Dosed LSD

Psychedelic Stocks
NEWS
INDUSTRY
INVESTING
COMPANIES
EXCLUSIVE

Newsletter

Get The Seed Investor straight to your email.

Copyright © 2016-2021, The Seed Investor | About | Contact | Advertise | Privacy Policy | Disclaimer
Powered by StructureCMS
The Seed Investor